Selected ressource details
-
Back
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
journal Article
2023
Web link: www.frontiersin.org/articles/...
Pages: 1133414